Bank of America Corporation »

Apellis Pharmaceuticals shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $36M 598k 59.86
2023-09-30 $34M 886k 38.04
2023-06-30 $39M 426k 91.10
2023-03-31 $40M 608k 65.96
2022-12-31 $24M 469k 51.71
2022-06-30 $17M 368k 45.22
2021-12-31 $13M 275k 47.28
2021-06-30 $15M 240k 63.20
2021-03-31 $15M 358k 42.91
2020-12-31 $8.7M 152k 57.20
2020-09-30 $3.7M 124k 30.17
2020-06-30 $5.8M 179k 32.66
2020-03-31 $5.7M 213k 26.79
2019-12-31 $6.0M 195k 30.62
2019-09-30 $3.6M 149k 24.09
2019-03-31 $3.8M 193k 19.50
2018-12-31 $232k 18k 13.21
2018-06-30 $465k 21k 22.01
2018-03-31 $24k 1.1k 22.37
2017-12-31 $30k 1.4k 21.80